Erlotinib Safety Questions, Erlotinib Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Erlotinib side effects. Check out Health Surveys and Health Polls. If you have questions about Erlotinib, you can post them to our Doctors or Ask Patient Community about Erlotinib.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Erlotinib
Erlotinib Safety Reports
Total Erlotinib reports: 392.Erlotinib FDA safety alerts: No.
Reported deaths: 110 Reported hospitalizations: 307.
Take Erlotinib Side Effects Survey or Share Your Erlotinib Story.
Reported Erlotinib Side Effects: disease progression, asthenia, anaemia, dehydration, haemoglobin decreased, pulmonary embolism, nausea, diarrhoea, diarrhoea haemorrhagic, vomiting, malignant neoplasm progression.
More About Erlotinib.
Showing 1-50 of 392 Next >
Erlotinib Side Effects Report #5248432-6Physician from UNITED STATES reported ERLOTINIB problem on Feb 06, 2007. Male patient, 72 years of age, weighting 171.7 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: disease progression, haemoglobin decreased, pneumonia, respiratory distress, respiratory failure. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with PREDNISONE, LISINOPRIL, ATENOLOL. Patient was hospitalized. Patient died on 01/18/2007.
Erlotinib Side Effects Report #5249143-3
ERLOTINIB problem was reported by a Physician from FRANCE on Feb 07, 2007. Male patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: gastroenteritis, headache. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with ZOLPIDEM TARTRATE, VITAMIN B, DI ANTALVIC. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5250757-5
Physician from GERMANY reported ERLOTINIB problem on Feb 09, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, chest pain, constipation, dehydration, disease progression, fall, infection. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5251949-1
ERLOTINIB problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Male patient, 56 years of age, weighting 110.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: application site bleeding, gastrectomy, large intestinal haemorrhage, rectal haemorrhage. ERLOTINIB dosage: 50 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5251951-X
Physician from UNITED STATES reported ERLOTINIB problem on Feb 07, 2007. Male patient, 74 years of age, weighting 145.1 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: bacterial infection, bronchoscopy abnormal, dysphagia, necrosis, odynophagia, oesophagitis, oral intake reduced, sputum purulent. ERLOTINIB dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5258597-8
ERLOTINIB problem was reported by a Physician from UNITED KINGDOM on Feb 16, 2007. Female patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: condition aggravated, non-small cell lung cancer metastatic. ERLOTINIB dosage: 150 MG (QD), ORAL. Patient died.
Erlotinib Side Effects Report #5259452-X
Physician from UNITED STATES reported ERLOTINIB problem on Feb 20, 2007. Female patient, 57 years of age, weighting 160.0 lb, was diagnosed with ovarian cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: hypertension, nausea. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, ATIVAN, ANZEMET. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5259638-4
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, 60 years of age, weighting 154.1 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. ERLOTINIB dosage: 150 MG (QD), ORAL. Patient was hospitalized and became disabled. Patient recovered.
Erlotinib Side Effects Report #5259639-6
Health Professional from UNITED STATES reported ERLOTINIB problem on Feb 20, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, dizziness, dyspnoea exertional, gait disturbance, movement disorder, nausea, oesophageal pain. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5259650-5
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, 71 years of age, was diagnosed with neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, atrial flutter, bacteraemia, bacterial infection, beta haemolytic streptococcal infection, blood pressure increased, cerebral infarction, diarrhoea, embolic stroke. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with CISPLATIN, DOCETAXEL, IMODIUM, HYDROCODONE, DEXAMETHASONE, ZOFRAN. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5261427-1
Consumer or non-health professional from FRANCE reported ERLOTINIB problem on Feb 21, 2007. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: acute respiratory failure, globulins decreased, overdose. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with ANTIVITAMIN K, AMIODARONE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5261428-3
ERLOTINIB problem was reported by a Physician from ITALY on Feb 21, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. ERLOTINIB dosage: 150 MG (QD), ORAL. Patient died on 07/05/2006.
Erlotinib Side Effects Report #5262258-9
Pharmacist from UNITED STATES reported ERLOTINIB problem on Mar 08, 2007. Male patient, 63 years of age, weighting 218.3 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, diarrhoea, liver function test abnormal. ERLOTINIB dosage: 150 MG ONCE DAILY PO. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5262366-2
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Mar 09, 2007. Male patient, weighting 169.0 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: atelectasis, disease progression, obstructive airways disorder, pleural effusion, pneumonia. ERLOTINIB dosage: 175MG DAILY PO. During the same period patient was treated with NORVASC, NEXIUM, NOVOLOG, LANTUS, PRANDIN, VYTORIN, AMBIEN, OXYCODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5266887-8
Health Professional from UNITED STATES reported ERLOTINIB problem on Feb 15, 2007. Female patient, 71 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: areflexia, aspiration, bacterial infection, blood creatine phosphokinase bb increased, blood sodium decreased, cardiac arrest, cardiac failure, cardiogenic shock, computerised tomogram abnormal. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, TYLENOL, VITAMIN, ASPIRIN, ZANTAC, METOPROLOL TARTRATE, COMPAZINE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5268193-4
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Mar 14, 2007. Male patient, weighting 205.0 lb, was diagnosed with pancreatic carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: asthenia, diarrhoea, heart rate increased, pyrexia, respiratory rate increased. ERLOTINIB dosage: 150 MG ONCE A DAY PO. During the same period patient was treated with XELODA, PANCREASE, PREVACID, ZOLOFT, IMODIUM, ZOFRAN, LOMOTIL, TINCTURE OF OPIUM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5268194-6
Health Professional from UNITED STATES reported ERLOTINIB problem on Mar 14, 2007. Male patient, weighting 154.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, disease progression. ERLOTINIB dosage: 150MG DAILY PO. During the same period patient was treated with MORPHINE SULPHATE, DILAUDID, COLACE, ZOFRAN, COMPAZINE, TEMAZEPAM, NEXIUM, MEGACE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5268852-3
ERLOTINIB problem was reported by a Physician from ITALY on Feb 23, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: disease progression. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with FENTANYL, LACTULOSE, PAROXETINE, PREDNISONE, ESOMEPRAZOLE, PHENOBARBITAL. Patient died.
Erlotinib Side Effects Report #5269919-6
Physician from UNITED STATES reported ERLOTINIB problem on Feb 27, 2007. Male patient, 76 years of age, weighting 178.6 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: ileus, small intestinal obstruction. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, TOPROL, LIPITOR, NIASPAN, NITROSTAT, ASPIRIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5269923-8
ERLOTINIB problem was reported by a Physician from UNITED STATES on Feb 26, 2007. Female patient, 58 years of age, was diagnosed with glioblastoma multiforme and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, red blood cell count decreased, thrombocytopenia, white blood cell count decreased. ERLOTINIB dosage: 200 MG (QD), ORAL. During the same period patient was treated with WAFARIN, DECADRON, PERCOCET, KEPPRA, LIPITOR. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5270340-5
Physician from DENMARK reported ERLOTINIB problem on Feb 27, 2007. Female patient, 46 years of age, was diagnosed with gastrointestinal carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: dysphagia, oesophagobronchial fistula. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, LYRICA, PRIMPERAN, LACTULOSE, ACTILAX, PREDNISOLONE, LORAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5270563-5
ERLOTINIB problem was reported by a Physician from UNITED STATES on Mar 10, 2007. Male patient, 25 years of age, weighting 187.4 lb, was diagnosed with rectal cancer, colon cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pain, purulence, subcutaneous abscess. ERLOTINIB dosage: 100 MG, QD, ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, AVASTIN, LEUCOVORIN CALCIUM, CLEOCIN T GEL, ELIDEL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5271875-1
Physician from SPAIN reported ERLOTINIB problem on Mar 02, 2007. Female patient, 44 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: cerebral artery embolism, coagulopathy, metastases to central nervous system. ERLOTINIB dosage: 100 MG (QD); ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5273618-4
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Male patient, weighting 205.0 lb, was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: diarrhoea haemorrhagic, hypokalaemia, pyrexia. ERLOTINIB dosage: unknown. During the same period patient was treated with XELODA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5277737-8
Physician from UNITED STATES reported ERLOTINIB problem on Mar 02, 2007. Female patient, 75 years of age, weighting 129.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, blood glucose increased, confusional state, convulsion, haemoglobin decreased, hypocalcaemia, hypokalaemia, hypomagnesaemia, mucosal dryness. ERLOTINIB dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5277740-8
ERLOTINIB problem was reported by a Physician from UNITED STATES on Mar 05, 2007. Male patient, 60 years of age, weighting 154.1 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: eating disorder, fall, pain, pulmonary embolism. ERLOTINIB dosage: 150 MG (QD), ORAL. Patient was hospitalized and became disabled. Patient recovered.
Erlotinib Side Effects Report #5277741-X
Consumer or non-health professional from UNITED STATES reported ERLOTINIB problem on Mar 05, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood culture positive, febrile neutropenia, white blood cell count decreased. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5281328-2
ERLOTINIB problem was reported by a Physician from FRANCE on Jan 08, 2007. Female patient, 56 years of age, was diagnosed with ovarian cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: small intestinal obstruction. ERLOTINIB dosage: 100 MG (QD), ORAL. During the same period patient was treated with PAROXETINE, LOCTAMIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5284210-X
Health Professional from UNITED STATES reported ERLOTINIB problem on Mar 30, 2007. Female patient, 72 years of age, weighting 151.5 lb, was diagnosed with salivary gland cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anorexia, blood sodium decreased, eye infection, fatigue, nausea, oral discomfort, staphylococcal infection, vomiting. ERLOTINIB dosage: 75 MG PO QD. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5284467-5
ERLOTINIB problem was reported by a Physician from UNITED KINGDOM on Mar 20, 2007. Female patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood gases abnormal, chronic obstructive pulmonary disease, convulsion, dyspnoea, hyponatraemia, inappropriate antidiuretic hormone secretion, infection, lower respiratory tract infection, lung neoplasm malignant. ERLOTINIB dosage: unknown. During the same period patient was treated with SALBUTAMOL, SALMETEROL, ATROVENT, BENDROFLUAZIDE, PREDNISOLONE, MAXOLON, TEMAZEPAM. Patient was hospitalized. Patient died on 12/30/2006.
Erlotinib Side Effects Report #5285479-8
Physician from UNITED STATES reported ERLOTINIB problem on Mar 12, 2007. Female patient, 82 years of age, weighting 128.3 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, ejection fraction decreased, pulmonary hypertension, ventricular dysfunction. ERLOTINIB dosage: 150 MG (QD) ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5285904-2
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Female patient, 37 years of age, weighting 276.0 lb, was diagnosed with neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: bone disorder, pain. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAG, IBUPROFEN, PERCOCET, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5285907-8
Health Professional from UNITED STATES reported ERLOTINIB problem on Mar 13, 2007. Male patient, 69 years of age, weighting 196.9 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: atelectasis, body temperature increased, cough, dyspnoea, haemoptysis, lung consolidation, lymphadenopathy, pain, pericardial effusion. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5286241-2
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Female patient, 31 years of age, weighting 180.3 lb, was diagnosed with ovarian cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, enterocutaneous fistula, haematocrit decreased, platelet count increased, white blood cell count increased. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5286987-6
Physician from PERU reported ERLOTINIB problem on Mar 14, 2007. Female patient, 54 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blood glucose increased, dehydration, gastrointestinal infection, prothrombin time prolonged. ERLOTINIB dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, GLYBURIDE, METFORMIN, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, TRAMADOL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5290184-8
ERLOTINIB problem was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 76 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, pulmonary embolism. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5291382-X
Physician from UNITED KINGDOM reported ERLOTINIB problem on Mar 19, 2007. Female patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. ERLOTINIB dosage: 150 MG (QD), ORAL. Patient died.
Erlotinib Side Effects Report #5295994-9
ERLOTINIB problem was reported by a Physician from UNITED STATES on Apr 05, 2007. Female patient, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease. ERLOTINIB dosage: 150 MG, QD. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5300166-5
Physician from UNITED STATES reported ERLOTINIB problem on Mar 26, 2007. Male patient, 71 years of age, weighting 181.9 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: bladder cancer, haemorrhage, penile pain. ERLOTINIB dosage: 100 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, PEMETREXED, LIPITOR, FLOMAX, ENALAPRIL MALEATE, ACTOS, CLARITIN, ATENOLOL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5300167-7
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Mar 26, 2007. Male patient, 80 years of age, weighting 173.9 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pain in extremity, pulmonary embolism, sinus tachycardia. ERLOTINIB dosage: 100 MG QD, ORAL. During the same period patient was treated with GEMCITABINE, GLIMEPIRIDE, GLYBURIDE, SIMVASTATIN, VICODIN, LYRICA, PEPCID AC, SENOKOT. Patient recovered.
Erlotinib Side Effects Report #5300467-0
Health Professional from UNITED STATES reported ERLOTINIB problem on Mar 26, 2007. Female patient, 57 years of age, weighting 160.0 lb, was diagnosed with ovarian cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: dehydration, hypertension, nausea, vomiting. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, ATIVAN, ANZEMET. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5301236-8
ERLOTINIB problem was reported by a Physician from KOREA, REPUBLIC OF on Mar 26, 2007. Female patient, 43 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pneumonia. ERLOTINIB dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5301239-3
Physician from AUSTRIA reported ERLOTINIB problem on Mar 26, 2007. Female patient was diagnosed with ovarian cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: hypercholesterolaemia, hypertriglyceridaemia, optic ischaemic neuropathy. ERLOTINIB dosage: 150 MG QD, ORAL. Patient recovered.
Erlotinib Side Effects Report #5301498-7
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Female patient was diagnosed with pancreatic carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, pancreatic carcinoma metastatic, pulmonary embolism. ERLOTINIB dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized and became disabled. Patient recovered.
Erlotinib Side Effects Report #5304684-5
Physician from FRANCE reported ERLOTINIB problem on Dec 15, 2006. Female patient, child 4 years of age, was diagnosed with ependymoma malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: coma, disease progression, neurological symptom, tumour haemorrhage. ERLOTINIB dosage: 100 MG, ORAL. During the same period patient was treated with ACETAMINOPHEN, PREDNISOLONE. Patient was hospitalized. Patient died on 12/05/2006.
Erlotinib Side Effects Report #5305172-2
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Male patient, 54 years of age, was diagnosed with hepatic neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, failure to thrive, hallucination, oral intake reduced. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, MARINOL, ATENOLOL, NEXIUM, SENOKOT, FENTANYL PATCH, ACTIQ. Patient was hospitalized. Patient died on 03/16/2007.
Erlotinib Side Effects Report #5305173-4
Health Professional from UNITED STATES reported ERLOTINIB problem on Mar 30, 2007. Female patient, 62 years of age, weighting 259.0 lb, was diagnosed with colorectal cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anaemia, bacterial infection, blood culture positive, dehydration, febrile neutropenia, hypertension, nausea, vomiting. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, ARANESP, LOMOTIL, ZOMETA, CIPRO. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5306618-6
ERLOTINIB problem was reported by a Physician from FRANCE on Apr 02, 2007. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with GLICLAZIDE, IRBESARTAN, ALMOR. Patient died on 11/15/2006.
Erlotinib Side Effects Report #5306983-X
Health Professional from UNITED STATES reported ERLOTINIB problem on Apr 03, 2007. Female patient, 70 years of age, was diagnosed with ovarian cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: vision blurred, visual disturbance. ERLOTINIB dosage: 150 MG (Q3W), ORAL. During the same period patient was treated with PEMETREXED, PROTONIX, FOSAMAX, SYNTHROID, DARVOCET, VITAMIN, PROCRIT. Patient was hospitalized and became disabled. Patient recovered.
Erlotinib Side Effects Report #5307352-9
ERLOTINIB problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Male patient, weighting 149.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, pneumonia. ERLOTINIB dosage: 150 MG, QD. During the same period patient was treated with AVASTIN, HYDROCODONE, IMODIUM, PROCHLORPERAZINE, MEGACE. Patient died on 04/20/2007.
Showing 1-50 of 392 Next >